Articles related to OBESITY/WEIGHT MANAGEMENT

Metformin is emerging as a viable option for weight management in obese patients without diabetes, showing sustained weight loss effects and potential benefits in populations with prediabetes or undergoing antipsychotic treatment.

AABP represents a significant yet under-recognized consequence of obesity, requiring a multidisciplinary treatment strategy that transcends conventional weight loss advice and addresses the intricate psychological and physical needs of affected individuals.

Recent studies reveal that adding ezetimibe to lower-intensity statin therapy is as effective as high-intensity statin therapy alone in preventing major cardiovascular events, offering a new approach to lipid management in patients intolerant to high-intensity statins.

Discover a compelling case of idiopathic intracranial hypertension linked to severe obesity, highlighting the critical importance of early diagnosis and the dual approach of medication and lifestyle changes in treatment.

The significant reduction in the incidence of death from cardiovascular causes, nonfatal MI, or nonfatal stroke highlights the need for further research into the benefits of semaglutide in this patient population.

This study suggests that a positive approach, presenting weight loss treatment as an opportunity, may be more effective in encouraging patients to take up treatment and achieve weight loss.